Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 81.70
-1.29 (-1.55%)
Sep 12, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 951.15 | 827.6 | 555.45 | 287.02 | 181.2 | 116.57 | Upgrade |
Depreciation & Amortization | 75.38 | 65.72 | 58.69 | 48.07 | 43.15 | 38.17 | Upgrade |
Other Amortization | 27.32 | 27.73 | 9.53 | 2.3 | 1.18 | 0.64 | Upgrade |
Loss (Gain) From Sale of Assets | 0.05 | 0.03 | 0.87 | -0.03 | 1.8 | 1.13 | Upgrade |
Asset Writedown & Restructuring Costs | 0.24 | - | 12.76 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -4.86 | -4.94 | -6.2 | -3.92 | -6.78 | -4.84 | Upgrade |
Provision & Write-off of Bad Debts | 2.51 | 3.72 | 0.35 | -1.41 | -2.34 | -0.19 | Upgrade |
Other Operating Activities | 0.5 | 0.48 | 1.72 | 0.59 | 1.58 | 2.8 | Upgrade |
Change in Accounts Receivable | -254.57 | -404.83 | -205.76 | -15.51 | -24.54 | -42.42 | Upgrade |
Change in Inventory | -91.08 | -76.53 | -57.29 | -13.24 | -16.87 | -29.02 | Upgrade |
Change in Accounts Payable | -2.47 | 0.45 | 153.19 | 61.89 | 63.92 | 9.69 | Upgrade |
Change in Other Net Operating Assets | 42.49 | 16.1 | - | - | - | - | Upgrade |
Operating Cash Flow | 718.78 | 430.63 | 512.1 | 363.16 | 234.78 | 92.61 | Upgrade |
Operating Cash Flow Growth | 34.64% | -15.91% | 41.01% | 54.68% | 153.52% | -24.89% | Upgrade |
Capital Expenditures | -219.39 | -251.35 | -288.46 | -219.17 | -190.93 | -118.81 | Upgrade |
Sale of Property, Plant & Equipment | -0 | 0.03 | 0.04 | 0.11 | 0.34 | 0.06 | Upgrade |
Investment in Securities | -5.79 | -57.29 | -17.35 | -70.34 | 78.66 | -264.18 | Upgrade |
Other Investing Activities | - | - | - | - | 0.09 | 0.94 | Upgrade |
Investing Cash Flow | -225.19 | -308.62 | -305.76 | -289.4 | -111.84 | -381.99 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 10 | 18.92 | Upgrade |
Total Debt Issued | 10 | - | - | - | 10 | 18.92 | Upgrade |
Short-Term Debt Repaid | - | - | - | -10 | -18.92 | -60 | Upgrade |
Long-Term Debt Repaid | - | -6.23 | -6.26 | -7.69 | -4.61 | - | Upgrade |
Total Debt Repaid | -7.25 | -6.23 | -6.26 | -17.69 | -23.53 | -60 | Upgrade |
Net Debt Issued (Repaid) | 2.75 | -6.23 | -6.26 | -17.69 | -13.53 | -41.08 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 348.16 | Upgrade |
Common Dividends Paid | -252.36 | -166.79 | -86.65 | -40.68 | -20.68 | -12.72 | Upgrade |
Other Financing Activities | - | - | - | - | - | -13.24 | Upgrade |
Financing Cash Flow | -249.62 | -173.02 | -92.91 | -58.37 | -34.2 | 281.11 | Upgrade |
Foreign Exchange Rate Adjustments | 0.1 | -0.13 | -1.11 | 0.03 | -0.49 | -0.96 | Upgrade |
Net Cash Flow | 244.07 | -51.14 | 112.32 | 15.42 | 88.25 | -9.23 | Upgrade |
Free Cash Flow | 499.38 | 179.28 | 223.64 | 143.99 | 43.85 | -26.2 | Upgrade |
Free Cash Flow Growth | 86.99% | -19.84% | 55.31% | 228.34% | - | - | Upgrade |
Free Cash Flow Margin | 15.91% | 6.36% | 10.65% | 9.43% | 3.87% | -3.30% | Upgrade |
Free Cash Flow Per Share | 1.22 | 0.44 | 0.55 | 0.36 | 0.11 | -0.07 | Upgrade |
Cash Income Tax Paid | 241.25 | 228.82 | 168.12 | 112.85 | 71.33 | 63.82 | Upgrade |
Levered Free Cash Flow | 267.24 | -44.25 | 41.08 | 127.17 | 11.47 | -64.97 | Upgrade |
Unlevered Free Cash Flow | 267.62 | -43.96 | 41.4 | 127.56 | 12.14 | -63.43 | Upgrade |
Change in Working Capital | -333.52 | -489.7 | -121.08 | 30.53 | 14.99 | -61.67 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.